Shopping Cart
- Remove All
Your shopping cart is currently empty
GB1107 is an effective and selective Galectin-3 inhibitor with a Kd of 37 nM.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $54 | In Stock | |
| 5 mg | $128 | In Stock | |
| 10 mg | $219 | In Stock | |
| 25 mg | $466 | In Stock | |
| 50 mg | $796 | In Stock | |
| 100 mg | $1,160 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $147 | In Stock |
| Description | GB1107 is an effective and selective Galectin-3 inhibitor with a Kd of 37 nM. |
| Targets&IC50 | GAL3 (human):(kd)37 nM |
| In vitro | GB1107 (0-1 μM) increases CD8+ T cell infiltration and tumor M1 macrophage polarization. GB1107 potentiates the effects of a PD-L1 immune checkpoint inhibitor to increase the expression of cytotoxic and apoptotic effector molecules including perforin-1, Fas ligand, IFN-γ, granzyme B, and cleaved caspase-3[1]. |
| In vivo | In CD-1 nude female mice received 3x106 human lung adenocarcinoma cells (A549), GB1107 (10 mg/kg, p.o.) significantly reduces tumor growth and final tumor weights[1]. |
| Synonyms | (2R,3R,4S,5R,6R)-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-4-[4-(3,4,5-trifluorophenyl)triazol-1-yl]oxane-3,5-diol |
| Molecular Weight | 522.32 |
| Formula | C20H16Cl2F3N3O4S |
| Cas No. | 1978336-61-6 |
| Smiles | OC[C@H]1O[C@H](Sc2ccc(Cl)c(Cl)c2)[C@H](O)[C@H]([C@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1 |
| Relative Density. | 1.73 g/cm3 (Predicted) |
| Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (86.15 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.83 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.